Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 16, 2013 09:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Present at 6th Annual Livingston Securities Life Science Stakeholders Summit

SUNNYVALE, Calif., Oct. 16, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
October 14, 2013 12:09 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Positive Analytical Performance Data for LymPro Test(R) for Alzheimer's Disease

SUNNYVALE, Calif., Oct. 14, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
October 03, 2013 08:45 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Enters Into Letter of Intent With Renishaw for Convection-Enhanced Delivery of MANF in Parkinson's Disease

SUNNYVALE, Calif., Oct. 3, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
September 27, 2013 06:35 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Bioscience Holdings Announces 2nd Closing of Private Placement

SUNNYVALE, Calif., Sept. 27, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
September 24, 2013 08:45 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Present at 2013 Aegis Healthcare Conference

SUNNYVALE Calif., Sept. 24, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
September 13, 2013 11:17 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Appoints F. Randall Grimes, MBA as Director of Sponsored Research

SUNNYVALE, Calif., Sept. 13, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS) a biotechnology company focused on the discovery and development of novel diagnostics and...
September 09, 2013 09:53 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus CEO to Present at the 15th Annual Rodman & Renshaw Global Investor Conference

SUNNYVALE, Calif., Sept. 9, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS) a biotechnology company focused on the discovery and development of novel diagnostics and...
September 04, 2013 09:24 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Bioscience Holdings Announces Private Placement of Convertible Debentures and Warrants

SUNNYVALE, Calif., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
September 03, 2013 09:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Appoints Dr. Colin Bier to Advisory Board for LymPro Commercialization

SUNNYVALE, Calif., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS) a biotechnology company focused on the discovery and development of novel diagnostics and...
August 29, 2013 10:11 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus CEO to Present at the 2nd Annual European Investing and Partnering Summit in Helsinki

SUNNYVALE, Calif., Aug. 29, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS) a biotechnology company focused on the discovery and development of novel diagnostics and...